Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Mallinckrodt Plc (MNK)

Mallinckrodt Plc (MNK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Mallinckrodt Presents Data on a Novel Predictive Model to Identify Infants at Risk for Infantile Spasms (IS) at the 2019 Annual Meeting of the American Epilepsy Society (AES)

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced findings on the use of a novel predictive model designed to more quickly identify infants with infantile spasms (IS), a...

MNK : 3.41 (+0.89%)
Mallinckrodt (MNK) Up 28.5% Since Last Earnings Report: Can It Continue?

Mallinckrodt (MNK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MNK : 3.41 (+0.89%)
Mallinckrodt plc Announces Final Results of Exchange Transactions

Mallinckrodt plc (NYSE: MNK) today announced (1) the final results of the previously announced offers by its wholly owned subsidiaries, Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC...

MNK : 3.41 (+0.89%)
J&J's (JNJ) New Tests Reveal No Asbestos in Baby Powders

J&J (JNJ) says that two third-party labs conducted 155 tests on samples of its baby powders. All these tests confirm that the talc does not contain asbestos, a known carcinogen.

JNJ : 140.38 (+0.59%)
ENDP : 4.84 (+0.41%)
TEVA : 9.92 (+1.02%)
MNK : 3.41 (+0.89%)
Mallinckrodt Moves Date and Time of Its Fireside Chat at Piper Jaffray Annual Healthcare Conference

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, announced today that the Company now will present at the Piper Jaffray Annual Healthcare Conference on Wednesday, Dec. 4, 2019 at 12:30...

MNK : 3.41 (+0.89%)
Fed Reportedly Opens Criminal Investigation on Opioid Makers

Shares of some manufacturers and distributors of opioid drugs decline on Tuesday following reports that a criminal probe has been initiated by federal prosecutors.

JNJ : 140.38 (+0.59%)
ENDP : 4.84 (+0.41%)
MNK : 3.41 (+0.89%)
TEVA : 9.92 (+1.02%)
MCK : 142.27 (+1.18%)
ABC : 88.24 (+0.48%)
AMRX : 3.68 (-0.81%)
Data on Acthar® Gel (Repository Corticotropin Injection) Therapy in Symptomatic Sarcoidosis Published in Therapeutic Advances in Respiratory Disease

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced findings from a large retrospective study of Acthar® Gel (repository corticotropin injection) in the treatment of the...

MNK : 3.41 (+0.89%)
Mallinckrodt Rises 4.53% on Heavy Volume: Watch For Potential Pullback

Mallinckrodt (NYSE:MNK) traded in a range yesterday that spanned from a low of $3.10 to a high of $3.25. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $3.16...

MNK : 3.41 (+0.89%)
Endo's (ENDP) BLA for Cellulite Treatment Accepted by FDA

The FDA accepts Endo's (ENDP) BLA for CCH for the treatment of cellulite in the buttocks.

ENDP : 4.84 (+0.41%)
JAZZ : 149.46 (+0.92%)
MNK : 3.41 (+0.89%)
TEVA : 9.92 (+1.02%)
Mallinckrodt plc Announces Early Results of Exchange Transactions

Mallinckrodt plc (NYSE: MNK) today announced (1) the early results of the previously announced offers by its wholly owned subsidiaries, Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC...

MNK : 3.41 (+0.89%)
Mallinckrodt to Present at Piper Jaffray Annual Healthcare Conference

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, will present on Tuesday, Dec. 3, 2019, at the Piper Jaffray Annual Healthcare Conference at the Lotte New York Palace, 455 Madison Ave,...

MNK : 3.41 (+0.89%)
Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced data on patient-reported outcomes (PROs) showing Acthar® Gel (repository corticotropin injection) improved disease measures...

MNK : 3.41 (+0.89%)
Mallinckrodt Presents Positive Phase 3 Results from its CONFIRM Study of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1) at The Liver Meeting® 2019

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced results from its pivotal Phase 3 CONFIRM study to assess the efficacy and safety of its investigational agent terlipressin...

MNK : 3.41 (+0.89%)
Mallinckrodt to Present at Jefferies London Healthcare Conference

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, will present at the Jefferies London Healthcare Conference in London on Wednesday, Nov. 20, 2019.

MNK : 3.41 (+0.89%)
Mallinckrodt Announces Data Publication on the Treatment Effectiveness of Acthar® Gel (Repository Corticotropin Injection) for Resolution of Multiple Sclerosis Relapse in a U.S. Health Plan Population

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced the publication of "Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a U.S. Health Plan Population"...

MNK : 3.41 (+0.89%)
Mallinckrodt (MNK) Q3 Earnings Beat, Stock Down on Sales Miss

Mallinckrodt (MNK) misses on sales but beats on earnings in the third quarter of 2019.

PTLA : 29.21 (+3.03%)
LCI : 8.80 (+3.65%)
FGEN : 47.39 (+0.53%)
MNK : 3.41 (+0.89%)
Mallinckrodt (MNK) Q3 Earnings Beat Estimates

Mallinckrodt (MNK) delivered earnings and revenue surprises of 4.55% and -3.71%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

MNK : 3.41 (+0.89%)
Mallinckrodt: 3Q Earnings Snapshot

SURREY, Britain (AP) _ Mallinckrodt PLC (MNK) on Tuesday reported a third-quarter loss of $1.1 million, after reporting a profit in the same period a year earlier.

MNK : 3.41 (+0.89%)
Mallinckrodt plc Announces Exchange Offers and Consent Solicitations

Mallinckrodt plc (NYSE: MNK) today announced the commencement of private offers (each, an "Exchange Offer" and, collectively, the "Exchange Offers") by its wholly owned subsidiaries, Mallinckrodt International...

MNK : 3.41 (+0.89%)
Mallinckrodt plc Reports Earnings and Pipeline Advancements for the Third Quarter 2019 and Raises Adjusted Diluted Earnings Per Share Guidance Range for 2019

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today reported results for the three months ended September 27, 2019. Unless otherwise noted, the quarter comparisons are to the recast...

MNK : 3.41 (+0.89%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +0.46 , AIZ +1.17 , SBAC +0.55 , SO -0.62 , WELL -0.29
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar